Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Fitch Ratings
View:
Comment by BlueJays9293 on Jun 11, 2024 7:57pm
Wow.  Nice find Gebremeskel.  Doesn't sound good to me from Baxter's perspective.  I don't think they have a choice now, and will have to sell directly to PE.  Which is much much better for Spectral because then Vantive will be in the hands of deep pockets and access to capital that can actually pull off a buyout of PMX/EAA.  I look forward to PE taking over ...more  
Comment by mercedesman on Jun 11, 2024 11:06pm
Interesting BAX does have liquidity* but they will be focussed on getting their EBITDA leverage down  *Solid Liquidity: Liquidity is supported by cash on hand of $3.0 billion at Mar. 31, 2024, full availability under its $2.5 billion revolving credit facility due 2026, and full availability under its EUR200 million revolving credit facility due 2026.  But they have $2B in ...more  
Comment by BlueJays9293 on Jun 12, 2024 12:21am
"But they have $2B in debt maturities in the next 12 months." This is the essence of Baxter's debt woes.  Every year they will have about the same amount, if not much more, of debt that needs to be rolled over into new debt.  New debt, with a much higher interest rate than the bonds that originally came due.  The bonds that Baxter issued for that ill advised Hilrom ...more  
Comment by mercedesman on Jun 12, 2024 8:34am
Life's a Fitch and then you die ( in a Hillrom bed) 
Comment by BlueJays9293 on Jun 13, 2024 7:46pm
This caught my eye, from MM, "or maybe even a Japanese Co. with a >$1 T yen  MC ?" Obviously you are talking about Toray.  This is a very interesting thought MM, why not get paid all of the wholesale price of PMX, and also get paid the juicy part of the retail price and it's incredible mark up in the USA.  Makes more than perfect sense to me, especially considering ...more  
Comment by mercedesman on Jun 14, 2024 3:08pm
Agreed ...,pure spectralation... But one just never knows.  KOLs Walker and later Kellum were hired, by a major Japanese conglomerate, to run Trials and get this across the finish line, with the hope of opening up the worlds biggest and richest market ( North America) for their already proven/ accepted product ( in Japan and parts of Europe)  They also foresaw the need to have a ...more  
Comment by oilandgasman on Jun 15, 2024 9:46am
No chance McShill.
Comment by jdunlop on Jun 16, 2024 7:41am
Oily.....man, how's your day job going?, you must feel deflated pumping gas all day.
Comment by oilandgasman on Jun 16, 2024 10:12am
Deflated ? not as much as someone who's pumped a stock that is basically the same price it's been for 10 years and has almost double the float.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities